The role of interleukin-15 in the development and treatment of hematological malignancies.

Sindaco, Paola; Pandey, Hritisha; Isabelle, Colleen; Chakravarti, Nitin; Brammer, Jonathan Edward; Porcu, Pierluigi; Mishra, Anjali (2023). The role of interleukin-15 in the development and treatment of hematological malignancies. Frontiers in immunology, 14, p. 1141208. Frontiers Research Foundation 10.3389/fimmu.2023.1141208

[img]
Preview
Text
The_role.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (1MB) | Preview

Cytokines are a vital component of the immune system that controls the activation and growth of blood cells. However, chronic overexpression of cytokines can trigger cellular events leading to malignant transformation. The cytokine interleukin-15 (IL-15) is of particular interest, which has been shown to contribute to the development and progression of various hematological malignancies. This review will provide an overview of the impact of the immunopathogenic function of IL-15 by studying its role in cell survival, proliferation, inflammation, and treatment resistance. We will also review therapeutic approaches for inhibiting IL-15 in blood cancers.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory

UniBE Contributor:

Sindaco, Paola

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1664-3224

Publisher:

Frontiers Research Foundation

Language:

English

Submitter:

Pierrette Durand Lüthi

Date Deposited:

10 Jul 2023 10:39

Last Modified:

16 Jul 2023 02:27

Publisher DOI:

10.3389/fimmu.2023.1141208

PubMed ID:

37153603

Uncontrolled Keywords:

IL-15 blood cancer cytokine treatment

BORIS DOI:

10.48350/184620

URI:

https://boris.unibe.ch/id/eprint/184620

Actions (login required)

Edit item Edit item
Provide Feedback